Psychosis and depression - A neurobiological view

Psychiatria Danubina

Volumn 21, Issue SUPPL. 1, 2009, Pages 102-105

  Pregelj, Peter ^a  

^a UNIVERSITY PSYCHIATRIC HOSPITAL   (Slovenia)

Author keywords

Depression; Genes; Neurobiology; Psychosis; Schizophrenia

Indexed keywords

CONFERENCE PAPER; DEPRESSION; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENETIC SUSCEPTIBILITY; HUMAN; MEDICAL RESEARCH; MENTAL DISEASE; MOOD DISORDER; NEUROBIOLOGY; PATHOGENESIS; PSYCHOSIS;

BRAIN; COMORBIDITY; DEPRESSIVE DISORDER; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEURONAL PLASTICITY; PSYCHOTIC DISORDERS; RECEPTORS, DOPAMINE; RECEPTORS, GLUTAMATE; SOCIAL ENVIRONMENT;

EID: 70350331810     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (42)

1. Amar S, Shaltiel G, Mann L, Shamir A, Dean B, Scarr E, Bersudsky Y, Belmaker RH & Agam G: Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia. Int J Neuropsychopharmacol 2008; 11:197-205. (Pubitemid 351231825)
2. Badner JA & Gershon ES: Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002; 7:405-411 (Pubitemid 34499362)
3. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR & Caron MG: An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005; 122:261-273
4. Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR & Caron MG. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci U S A 2004; 101:5099-5104 (Pubitemid 38469209)
5. Berrettini W: Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am J Med Genet 2003; 123C:59-64. (Pubitemid 37356433)
6. Blackwood DH, Fordyce A, Walker MT, St Clair DM, Porteous DJ & Muir WJ: Schizophrenia and affective disorders - cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet 2001; 69:428-433
7. Cardno AG, Rijsdijk FV, Sham PC, Murray RM & McGuffin P: A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry 2002; 159:539-545 (Pubitemid 34274934)
8. Carter CJ: Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation, oxidative stress and oligodendrocyte viability. Schizophr Res 2006; 86:1-14.
9. Chubb JE, Bradshaw NJ, Soares DC, Porteous DJ & Millar JK: The DISC locus in psychiatric illness. Mol Psychiatry 2008; 13:36-64.
10. Craddock N, O'Donovan MC & Owen MJ: Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 2006; 32:9-16. (Pubitemid 43063811)
11. Devon RS, Evans KL, Maule JC, Christie S, Anderson S, Brown J, Shibasaki Y, Porteous DJ & Brookes AJ: Novel transcribed sequences neighbouring a translocation breakpoint associated with schizophrenia. Am J Med Genet 1997; 74:82-90.
12. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M & Gogos JA: Convergent evidence for impaired AKTl-GSK3beta signaling in schizophrenia. Nat Genet 2004; 36:131-137 (Pubitemid 38174370)
13. Frangos E, Athanassenas G, Tsitourides S, Katsanou N & Alexandrakou P: Prevalence of DSM III schizophrenia among the first-degree relatives of schizophrenic probands. Acta Psychiatr Scand 1985; 72:382-386 (Pubitemid 16192037)
14. Garey U, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM, Barnes TR & Hirsch SR: Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 1998; 65:446-453 (Pubitemid 28438871)
15. Glantz LA & Lewis DA: Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000; 57:65-73.
16. Goldman-Rakic PS, Castner SA, Svensson TH, Siever LI & Williams GV: Targeting the dopamine Dl receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl) 2004; 174:3-16. (Pubitemid 38925085)
17. Hof PR, Haroutunian V, Copland C, Davis KL & Buxbaum JD: Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochem Res 2002; 27:1193-1200 (Pubitemid 35316115)
18. Hof PR, Haroutunian V, Friedrich VL Jr, Byne W, Buitron C, Perl DP & Davis KL: Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biol Psychiatry 2003; 53:1075-1085 (Pubitemid 36695083)
19. Kang UG, Seo MS, Roh MS, Kim Y, Yoon SC & Kim YS: The effects of clozapine on the GSK-3-mediated signaling pathway. FEBS Lett 2004; 560:115-119 (Pubitemid 38264303)
20. Kendler KS, Karkowski LM & Walsh D: The structure of psychosis: Latent class analysis of probands from the Roscommon Family Study. Arch Gen Psychiatry 1998; 55:492-499
21. Kozlovsky N, Amar S, Belmaker RH & Agam G: Psychotropic drugs affect Ser9-phosphorylated GSK-3 beta protein levels in rodent frontal cortex. Int J Neuropsychopharmacol 2006; 9:337-342 (Pubitemid 43780501)
22. Krepelin E: Manic-Depressive Insanity and Paranoia. Edimburg: Livingstone, 1919.
23. Laruelle M, Kegeles LS & Abi-Dargham A: Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann N Y Acad Sci 2003; 1003:138-158 (Pubitemid 38083052)
24. Li M, Wang X, Meintzer MK, Laessig T, Birnbaum MJ & Heidenreich KA: Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta.
25. Li X, Rosborough KM, Friedman AB, Zhu W & Roth KA: Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. Int J Neuropsychopharmacol 2007; 10:7-19. (Pubitemid 46122748)
26. Mahadik SP & Scheffer RE: Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins Leukot Essent Fatty Acids 1996; 55:45-54.
27. McGuffin P, Reveley A & Holland A: Identical triplets: non-identical psychosis? Br J Psychiatry 1982; 140:1-6.
28. Millar JK, Brown J, Maule JC, Shibasaki Y, Christie S, Lawson D, Anderson S, Wilson-Annan JC, Devon RS, St Clair DM, Blackwood DH, Muir WJ & Porteous DJ: A long-range restriction map across 3 Mb of the chromosome 11 breakpoint region of a translocation linked to schizophrenia: localization of the breakpoint and the search for neighbouring genes. Psychiatr Genet 1998; 8:175-181
29. Millar JK, Christie S, Anderson S, Lawson D, Hsiao-Wei Loh D, Devon RS, Arveiler B, Muir WJ, Blackwood DH & Porteous DJ: Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol Psychiatry 2001; 6:173-178
30. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA, Devon RS, Clair DM, Muir WJ, Blackwood DH & Porteous DJ: Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000; 9:1415-1423 (Pubitemid 30312490)
31. Mol Cell Biol 2000; 20:9356-9363
32. Reddy RD & Yao JK: Free radical pathology in schizophrenia: a review. Prostaglandins Leukot Essent Fatty Acids 1996; 55:33-43.
33. Rice J, Reich T, Andreasen NC, Endicott J, Van Eerdewegh M, Fishman R, Hirschfeld RM & Klerman GL: The familial transmission of bipolar illness. Arch Gen Psychiatry 1987; 44:441-447
34. Rosoklija G, Toomayan G, Ellis SP, Keilp J, Mann JJ, Latov N, Hays AP & Dwork AJ: Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry 2000; 57:349-356 (Pubitemid 30202325)
35. St Clair D, Blackwood D, Muir W, Carothers A, Walker M, Spowart G, Gosden C & Evans HJ: Association within a family of a balanced autosomal translocation with major mental illness. Lancet 1990; 336:13-16 (Pubitemid 20207869)
36. Svenningsson P, Tzavara ET, Carruthers R, Rachleff I, Wattier S, Nehls M, McKinzie DL, Fienberg AA, Nomikos GG & Greengard P: Diverse psychotomimetics act through a common signaling pathway. Science 2003; 302:1412-1415 (Pubitemid 37452186)
37. Tsuang MT, Winokur G & Crowe RR: Morbidity risks of schizophrenia and affective disorders among first degree relatives of patients with schizophrenia, mania, depression and surgical conditions. Br J Psychiatry 1980; 137:497-504. (Pubitemid 11251315)
38. Uranova NA, Vostrikov VM, Orlovskaya DD & Rachmanova VI: Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 2004; 67:269-275
39. Vallès V, Van Os J, Guillamat R, Gutiérrez B, Campillo M, Gento P & Fananas L: Increased morbid risk for schizophrenia in families of inpatients with bipolar illness. Schizophr Res 2000; 42:83-90. (Pubitemid 30163074)
40. Vostrikov VM, Uranova NA, Rakhmanova VI & Orlovskaia DD: (Lowered oligodendroglial cell density in the prefrontal cortex in schizophrenia)
41. Yao JK, Reddy RD & van Kammen DP: Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 2001; 15:287-310. (Pubitemid 32337052)
42. Zh Nevrol Psikhiatr Im S S Korsakova 2004; 104:47-51. Russian.